Effectiveness and Safety of Dual Targeted Therapy for Partially or Non-Responsive Inflammatory Bowel Disease: A Meta-Analysis and Systemic Review

被引：0
|
作者：
Berinstein, Elliot [1 ]
Cohen-Mekelburg, Shirley [2 ]
Bishu, Shrinivas [2 ]
Higgins, Peter [3 ]
Berinstein, Jeffrey [3 ]
机构：
[1] Trin Hlth Ann Arbor, Ypsilanti, MI USA
[2] Univ Michigan, Ann Arbor, MI USA
[3] Univ Michigan Hosp, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S859
引用
收藏
页码：S635 / S636
页数：2
相关论文
共 50 条
  • [21] Biologics for Inflammatory Bowel Disease and Their Safety Pregnancy: A Systematic Review and Meta-analysis
    Nielsen, Ole Haagen
    Gubatan, John Mark
    Juhl, Carsten Bogh
    Streett, Sarah Elizabeth
    Maxwell, Cynthia
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 74 - +
  • [22] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, Fabio Salvatore
    Ventimiglia, Marco
    Orlando, Ambrogio
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1217 - 1227
  • [23] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, F. S.
    Ventimiglia, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 857 - 858
  • [24] Effectiveness and safety of vedolizumab in older versus younger adults with inflammatory bowel disease: A systematic review and meta-analysis
    Baker, J.
    Mountifield, R.
    Thynne, T.
    Zinellu, A.
    Barnes, A.
    Shanahan, E.
    Mangoni, A. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 118 - 118
  • [25] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Stefan Schreiber
    Axel Dignass
    Laurent Peyrin-Biroulet
    Greg Hather
    Dirk Demuth
    Mahmoud Mosli
    Rebecca Curtis
    Javaria Mona Khalid
    Edward Vincent Loftus
    Journal of Gastroenterology, 2018, 53 : 1048 - 1064
  • [26] The comparative effectiveness and safety of ustekinumab for different maintenance intervals in inflammatory bowel disease: A systematic review and meta-analysis
    Bai, Yaqing
    Sun, Yinghao
    He, Qi
    Bai, Xiaoyin
    Yang, Hong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 77 - 77
  • [27] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
  • [28] The comparative effectiveness and safety of ustekinumab for different maintenance intervals in inflammatory bowel disease: A systematic review and meta-analysis
    Bai, Yaqing
    Sun, Yinghao
    He, Qi
    Bai, Xiaoyin
    Yang, Hong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 77 - 77
  • [29] Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis
    Singh, Anupam Kumar
    Jha, Daya Krishna
    Jena, Anuraag
    Kumar-M, Praveen
    Sebastian, Shaji
    Sharma, Vishal
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E564 - E573
  • [30] Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis
    Singh, Anupam Kumar
    Jha, Daya Krishna
    Jena, Anuraag
    Kumar-M, Praveen
    Sebastian, Shaji
    Sharma, Vishal
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E564 - E573
12345